We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Ablation Therapy Could Treat Stomach Disorders by Correcting Abnormal Electrical Activation

By HospiMedica International staff writers
Posted on 04 May 2022
Print article
Image: Ablation therapy has demonstrated potential for treatment of gastric function disorders (Photo courtesy of Pexels)
Image: Ablation therapy has demonstrated potential for treatment of gastric function disorders (Photo courtesy of Pexels)

When dysrhythmic activity occurs in the heart, it results in irregular heartbeat, and a condition called atrial fibrillation. This is often treated with ablation therapy, the precise ‘burning’ of tissue to control the naturally occurring electricity in the heart. Now, researchers have demonstrated that the technique could also be applied to control the underlying bioelectrical “slow wave” activity in the stomach for the potential treatment of disorders of gastric function.

Last year, a team of researchers from the Auckland Bioengineering Institute (Auckland, New Zealand) had published the initial results of their research performing ablation in the stomach, demonstrating that it was possible to use ablation to block the electrical activation of the stomach in localized regions. In normal circumstances the stomach is coordinated by underlying bioelectrical “slow wave” activity, which coordinates the contraction of the muscles that mix and move contents into and through the gastrointestinal (GI) tract. When these electrical slow waves don’t work as they normally should, described as ‘stomach dysrhythmias’, it can lead to severe GI disorders and symptoms of nausea, vomiting, pain and bloating.

“The more recent paper builds on that foundational work, where we have targeted ablation to inhibit specific sites of electrical activation in the stomach,” said Dr. Tim Angeli-Gordon who supervised the research. “This is an important advance because we have now shown that we can eliminate abnormal electrical activation with ablation, and also that the normal electrical activation of the stomach can be restored after ablation. Although these studies were done in our pre-clinical lab, they demonstrate the powerful potential of ablation in the stomach which may now be able to be translated as a therapy for patients suffering from gastrointestinal disorders.”

Related Links:
Auckland Bioengineering Institute 

Gold Supplier
Conductive Gel
Electric Gynecological Operating Table
Premium Ultrasound System
RS85 Prestige

Print article
FIME - Informa



view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: New technology gives patients the power to heal chronic wounds using their own blood (Photo courtesy of RedDress)

POC Solution Creates In Vitro Blood Clots from Patient’s Own Whole Blood in Real-Time to Treat Post-Surgical Wounds

Blood clots are a natural mechanism of the body's healing process. However, for chronic wounds resulting from diabetes and other conditions, blood is unable to reach these areas, hampering the initiation... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: IntelliSep is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying ED patients with sepsis (Photo courtesy of Cytovale)

Rapid Microfluidic Test Demonstrates Efficacy as Diagnostic Aid to Improve Sepsis Triage in ED

Sepsis is the primary cause of mortality worldwide, accounting for over 350,000 fatalities annually in the United States alone, a figure that surpasses deaths from opioid overdoses, prostate cancer, and... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.